ARANX | CRDRX | ARANX / CRDRX | |
Total Expense Ratio | 1.28 | 0.82 | 156% |
Annual Report Gross Expense Ratio | 1.28 | 0.82 | 156% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 1.624 | 4.284 | 38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.32B | 2.4B | 55% |
Annual Yield % from dividends | 0.53 | 2.44 | 22% |
Returns for 1 year | -5.00 | 7.35 | -68% |
Returns for 3 years | 18.92 | 20.33 | 93% |
Returns for 5 years | 36.95 | 11.24 | 329% |
Returns for 10 years | 26.59 | 24.83 | 107% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 32.96 | -0.23 | -0.69% |
Eventide Healthcare & Life Sciences N | |||
PIGDX | 16.26 | -0.16 | -0.97% |
Federated Hermes International Growth IS | |||
AFICX | 83.75 | -0.93 | -1.10% |
American Funds Fundamental Invs C | |||
JAWWX | 117.22 | -1.52 | -1.28% |
Janus Henderson Global Research T | |||
HFAHX | 15.13 | -0.21 | -1.37% |
Hartford Schroders Intl Cntrrn Val Y |